 | Up a level |
Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Himmelsbach, Vera; Schulze, Kornelius; von Felden, Johann; Fründt, Thorben W; Stadler, Marc; Heinzl, Harald; Shmanko, Kateryna; Spahn, Stephan; Radu, Pompilia; Siebenhüner, Alexander R; Mertens, Joachim C; Rahbari, Nuh N; Kütting, Fabian; Waldschmidt, Dirk-Thomas; ... (2022). Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. Journal of hepatology, 76(2), pp. 353-363. Elsevier 10.1016/j.jhep.2021.09.035
Finkelmeier, Fabian; Scheiner, Bernhard; Leyh, Catherine; Best, Jan; Fründt, Thorben Wilhelm; Czauderna, Carolin; Beutel, Alica; Bettinger, Dominik; Weiß, Johannes; Meischl, Tobias; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Radu, Pompilia; Schultheiß, Michael; Peiffer, Kai-Henrik; Ettrich, Thomas J; Weinmann, Arndt; Wege, Henning; Venerito, Marino; Dufour, Jean-François; ... (2021). Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort. Liver cancer, 10(4), pp. 360-369. Karger 10.1159/000515490
Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; ... (2021). NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature, 592(7854), pp. 450-456. Springer Nature 10.1038/s41586-021-03362-0
Kolly, Philippe; Waidmann, Oliver; Vermehren, Johannes; Moreno, Christophe; Vögeli, Isabelle; Berg, Thomas; Semela, David; Zeuzem, Stefan; Dufour, Jean-François (2017). Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study. Journal of hepatology, 67(4), pp. 876-878. Elsevier 10.1016/j.jhep.2017.07.007
